1. Rowland M., Tozer T.N. (1995): Clinical Pharmacokinetics, Concepts and Applications, 3rd edn. London: Williams & Wilkins.
2. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. (1995): Pharm. Res., 12, 413–420.
3. Gleiter C.H., Klotz U., Kuhlmann J. et al. (1998): J. Clin. Pharm., 38, 908–911.
4. FDA Guideline: In vivo Bioequivalence studies based on Population and Individual Bioequivalence Approaches.
5. CPMP Guideline: Note for Guidance on the Investigation of Bioavailability and Bioequivalence.